← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2010Last known activity
Jan 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 5 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05563064Lead sponsorPhase 3Jan 1, 2021
- NCT05563064Reponsible party - principal investigatorPhase 3Jan 1, 2021
- NCT03506919Reponsible party - principal investigatorPhase 1/Phase 2Jan 1, 2018
- NCT03506919Lead sponsorPhase 1/Phase 2Jan 1, 2018
- NCT04443790Lead sponsorPhase 2Apr 10, 2015
- NCT04443790Sponsor investigatorPhase 2Apr 10, 2015
- NCT02642250Reponsible party - principal investigatorPhase 2/Phase 3Jan 1, 2015
- NCT02642250Lead sponsorPhase 2/Phase 3Jan 1, 2015
- NCT02004197Lead sponsorPhase 2/Phase 3Jan 1, 2010
- NCT02004197Sponsor investigatorPhase 2/Phase 3Jan 1, 2010
Details
- Last known activity
- Jan 1, 2021